Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia
Sign Up to like & getrecommendations! Published in 2020 at "CNS Spectrums"
DOI: 10.1017/s1092852920001728
Abstract: Abstract Background The present study aimed to determine whether the number of hospitalizations in schizophrenia patients is associated with reduced cognitive performance, which may in turn imply that recurrences indirectly lead to a worsening in… read more here.
Keywords: stable schizophrenia; number hospitalizations; effects number; cognitive performance ... See more keywords
Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic
Sign Up to like & getrecommendations! Published in 2023 at "CNS Spectrums"
DOI: 10.1017/s1092852923001645
Abstract: Abstract Introduction Lumateperone (LUMA) is an FDA-approved antipsychotic to treat schizophrenia and depressive episodes associated with bipolar I or bipolar II disorder. An open-label study (Study 303) evaluated the safety and tolerability of LUMA in… read more here.
Keywords: safety; ris pal; previous antipsychotic; stable schizophrenia ... See more keywords